Humans and rodents have similar brain structures that regulate empathy, suggesting the behavior is deeply rooted in mammal evolution.
The researchers are hoping the extremely light material could be used to construct lightweight exoskeletons and shape-shifting “Terminator 2”-style robots, New Scientist reports.
Glass Beads
Continue reading “Scientists Want to Build Robots out of Floating Liquid Metal” »
Early Bird ends TOMORROW!
Have you got your tickets yet? If not, then you just have a few hours to do so and save €200. Early Bird ends tomorrow 11:59 pm CET (15:00pm Pacific).
Accelerating rejuvenation therapies to repair the damage of aging.
Hype or hyper-exciting? Kate Batz of Longevity. Capital shares her views on the Longevity landscape and its investment potential: pragmatic optimism, but full of opportunity.
Should we be forced to die? Live? We’re going to dig into some deep questions about health and longevity in our discussion this week with the CEO of BioViva Sciences, Elizabeth Parrish. BioViva is dedicated to improving healthy human longevity through bioinformatics used in health predictions and recommendations, precision medicine, and the discovery of novel biomarkers by applying state of the art computational methods on vast collections of biological data.
For the first time, doctors have attempted to cure blindness by gene-hacking a patient with CRISPR technology.
A team from Oregon Health & Science Institute injected three droplets of fluid that delivered the CRISPR DNA fragments directly into a patient’s eyeball, The Associated Press reports, in hopes that it will reverse a rare genetic condition called Leber congenital amaurosis, which causes blindness early in childhood.
“We literally have the potential to take people who are essentially blind and make them see,” Charles Albright, chief scientific officer of Editas Medicine, told the AP.
The coronavirus outbreak in China has had a foreseeable but unintended consequence. Truck drivers have refused to make deliveries into areas either identified as or suspected of harboring the disease.
This has interrupted not only the flow of minerals out of the affected areas but also the refining and manufacturing of metals, food, and fuel. Among the under-reported deficiencies thereby caused the most important ones for the global rare earths production and utilization industries is the interruption in the flow of chemical reagents necessary for refining rare earths and for producing metals, alloys, and magnets.
Critical materials-based supply chains may be hanging by a thread, the thread of the size of existing Chinese inventories. The coronavirus outbreak in China has had a foreseeable but unintended consequence.
Continue reading “The inevitable impact of the Coronavirus on the world’s rare earths supply” »
Scientists say they have used the gene editing tool CRISPR inside someone’s body for the first time — offering a new frontier for efforts to operate on DNA, the chemical code of life, to treat diseases.
A patient recently had it done at the Casey Eye Institute at Oregon Health & Science University in Portland for an inherited form of blindness, according to the companies that make the treatment. The company would not give details on the patient or when the surgery occurred.
It may take up to a month to see if it worked to restore the patient’s vision. If the first few attempts seem safe, doctors plan to test it on 18 children and adults.
We would like to thank the many people who provided comments to our last coronavirus update at https://www.facebook.com/groups/lifeboatfoundation/permalink/10158676889983455/.
You can comment on this update at https://www.facebook.com/groups/lifeboatfoundation/permalink/10158683233098455/.
Here’s a lot of new information:
